2024 eastern region candidates 

Je-Yoel  Cho

Professor, Seoul National University, College of Veterinary Medicine, South Korea

Stuart Cordwell

Professor of Analytical Biochemistry, University of Sydney, Australia 

I have been an active member of HUPO since 2002. Currently, I am the Secretary-General of HUPO (2023-2025) on the Executive Committee, and am Chair of the Working Groups for HUPO Ambassadors and for the EMCR International Exchange Program. I also led efforts to provide a financial policy and procedure for HUPO that was ratified in 2024. I am committed to a HUPO that embraces diversity and inclusion, and have a long track record of successfully mentoring students and early career researchers. I was the President of the Australasian Proteomics Society from 2015-2020, and the Co-Chair (with Peter Hoffmann) of the HUPO World Congress held in Adelaide in 2019.  I have been involved in the organizing committees of several additional HUPO meetings, including as a member of the Core Committee for Toronto 2025. I was Vice-President of Asia-Oceania HUPO from 2020-2022.

I am Professor of Analytical Biochemistry in the Faculties of Science and Medicine and Health at the University of Sydney (Australia) and my entire career has been in proteomics research. My research interests lie in understanding membrane-associated and secreted virulence factors associated with human bacterial pathogens, and the role played by protein post-translational modifications in bacterial pathogenesis. I am strongly committed to proteomics education, having established the first undergraduate 'proteomics' course in Australia; each year training 70-80 final year undergraduates in hands-on proteomics and multi-omics science. I also appreciate the critical role played by core facilities in providing excellent proteomics services, having acted in the role of Academic Director for Sydney Mass Spectrometry since 2014. Although I have enjoyed many roles in HUPO, I have never before been a member of HUPO Council. If elected, I look forward to continuing to work with the proteomics community to provide more opportunities for young researchers, engaging further in collaboration with our Industry partners and in disseminating the possibilities of exploring proteomics with scientists from across the world

Laura Dagley

Head, WEHI Proteomics Facility,  Walter and Eliza Hall Institute of Medical Research, Australia

Since 2021, I have been the Proteomics Facility manager at The Walter and Eliza Hall Institute (WEHI). I have over 13 years' experience in the application of novel mass spectrometry and proteomics technologies to address key research questions in the fields of infectious & inflammatory diseases and cancer. I have broad leadership roles in local and international proteomics organisations and societies, including the Australasian Proteomics Society (board of management committee, 2019-current), HUPO (awards committee member, 2018-current and Human Plasma Proteome Project executive committee, 2021-current) and Proteomics and Metabolomics Victoria (PMV; 2019 president and current general member). In 2019 as PMV president, I organised 2 local symposia and established a collaboration between PMV and the Gene Technology Access Centre (GTAC) to address equity of access to STEM opportunities by engaging with Year 10 Work Experience students from Country Victoria.

As a member of the HUPO council, I am committed to ensuring gender diversity and equal representation across the regions to promote the HUPO vision. If I am elected to the council I would like to actively promote HUPO initiatives to attract the next generation of life scientists to be active society members, and to also create additional platforms for E/MCRs to contribute to HUPO.

Tiannan Guo

Tenured Associate Professor, Westlake University, China

I started my scientific career by learning clinical medicine, followed by proteomics and AI. Currently I am an associate professor leading a team of about 50 members.

I am honored to submit my application for re-election as a Council Member of the Human Proteome Organization (HUPO).

During my tenure from 2021 to 2023, I served in the Organizing Committee of Annual HUPO meeting, Marketing and Outreach Committees, Cancer Proteome of BD-HPP, and as the founding co-chair of the Education and Training Committee (ETC). With passionate MOC members, we have initiated WeChat for HUPO, which reached over 1,700 followers and 65,000 views with 160 original articles. With other passionate ETC members, we have initiated several webinar series that attracted over 30,000 viewers.

As a researcher with over 140 publications in proteomics, our key research outputs include the development of high-throughput proteomic analysis of biopsy tissue samples, expansion proteomics, and proteomic studies of COVID-19, and AI-based protein classification of thyroid nodules. We have also advanced the clinical translation of proteomics technologies.

I have also participated in the HPP programs (Grand Challenge project) and the piHub project by organising many domestic and international symposiums and conferences.

I also serve as an associate editor of MCP, advisor for Cell Reports Medicine, Proteomics, and serve in the editorial board of Scientific Data and Genomics Proteomics Bioinformatics.

If re-elected, I plan to contribute to the HUPO community in the following aspects:

1. Technology advancements, scientific discoveries, and clinical translations are the hard core of the HUPO community. I could potentially connect the HUPO community with the leading laboratories and leading journals.
2. Enhancing international collaborations in the Grand Challenge Project and the piHub project.
3. Helping next generation scientists to grow, and attract more talented young students to join us.
4. Promoting the clinical translation of proteomics, and attract more clinicians to join us

Daniel Kolarich

Principal Research Leader/Professor, Institute for Biomedicine and Glycomics, Griffith University , Australia 

If I am trusted by the members to serve on the HUPO council, I aim to be a representative for the Eastern (Asia/Oceania) region. Though I am from Austria initially, I now call Australia my home and of course aim to support the HUPO activities not just in the region but also beyond. I have been a HUPO member since 2008 and been active in supporting various HUPO organised activities, either as a contributor (e.g. towards previous Human Glyco/Proteomics Initiative (HGPI, 2004-2016)) or now as a co-chair of the Human Glycoproteomics Initiative (HGI).

My research has always focused on understanding the glycocode in health and disease by using MS-based approaches, with and without combination with LC. Glycoproteins have always been a particular interest, and to understand glycoprotein function, both the protein and glycan aspects of these need to be understood. Due to the nature of my research focus, I am well prepared to understand the needs and requirements not just for protein Post Translational Modification-related challenges, but also other Biology/Disease-Human Proteome Project (B/D-HPP) activities in HUPO.

My active contributions to the MIRAGE working group (= Minimum Information Required for A Glycomics Experiment) have also provided me with valuable experience and an understanding for the critical necessity for comprehensive reporting of experimental data that is imperative to advance any proteomics associated sciences. I also was an active part of a 5-person committee that was instrumental in establishing the Australian Glycoscience Society (AGS) in 2022, and I currently serve as the Vice-president of the AGS. Recently, I have been entrusted to participate in the HUPO Humanitarian Working Group, which aims at establishing mission statement for HUPO to navigate the complex political space this world has become.

Thus, I am convinced that my professional experiences and background will provide a benefit for HUPO and its members should I be trusted to serve on the HUPO council.

Qingsong Lin

Principal Research Fellow, National University of Singapore, Singapore

I have dedicated over 20 years to the fields of proteomics and mass spectrometry. Since the founding of the Singapore Society for Mass Spectrometry (SSMS) in 2005, I have been an active committee member, serving as the society's President during 2017- 2024. My efforts have been focused on promoting proteomics and mass spectrometry technologies by organizing conferences, seminars, and workshops. I have contributed as an organizing committee member for the Structural Biology and Functional Genomics Conference series and the 2006 AOHUPO conference. In 2017, I co-chaired the Asia-Oceania Mass Spectrometry Conference (AOMSC) and served on its international committee since then. Additionally, I am a council member of the Asia-Oceania Agricultural Proteomics Organization (AOAPO). As one of the Co-Chairs, I successfully organized the 11th AOHUPO and 7th AOAPO joint conference in Singapore in 2023. As the Director of the Protein and Proteomics Centre at the National University of Singapore, I run a proteomics core facility. I am also the Lead Principal Investigator of SingMass, Singapore's National Laboratory for Mass Spectrometry.

My passion lies in serving the proteomics community and advancing the field through continuous collaboration and innovation. I served as a HUPO council member from 2022 to 2024 and participated as a member of the HUPO Education and Training Committee. I am eager to continue contributing to the organization through another term.

Suman Thakur

Principal Scientist, Centre for Cellular and Molecular Biology (CCMB) Hyderabad, India

I am passionate about mass spectrometry bases proteomics and its application in basic and clinical science including understanding of cancer progression and its therapeutics. My research interests are advancement of proteomics technologies including single run, single cell and comprehensive proteomics, to find novel targets for cancer and diabetes using biomarker discovery and protein-protein interactions. Earlier, I had contributed in the development of single run technology in year 2011. Currently, I am associate editor in BB Reports and editorial board member of BBA Protein and Proteomics, Scientific Reports. I was also associated with Journal of Proteome Research (JPR) as its editorial board member and guest editor for the special issue on "Proteomics and its applications in pandemic disease" in JPR issue of November 2020 that had a collection of proteomics and metabolomics related article on COVID-19. Further, I had also got chance to bring a special issue entitled "Proteomics and its application in Endocrine disorders" as guest editor in BBA Protein and Proteomics containing a collection of endocrine disease in year 2021. Furthermore, as guest associate editor and topic editor with myself along with my colleagues had chance to bring a special issue entitled "Proteomics and its application in cancer" in Frontiers in Oncology in 2021. I had organized a proteomics brainstorm meeting with national and international speaker in year 2014 at Hyderabad, India as convener. I am a member of the HUPO family. Further, I am also life member of Proteomics society of India and earlier had chance to be Executive council member of Proteomics society of India from year 2014 to 2019.

I believe HUPO can play a great role in development of proteomics as platform for large scale studies in basic and clinical research and play an important role in the service of mankind. I would be very happy to be a part of executive council of HUPO and like to take forward the mandate of HUPO and provide help to the Proteomics community

Koji Ueda

Project Leader, Japanese Foundation For Cancer Research, Japan 

I have been a member of HUPO for 13 years and am currently active in two initiatives (ICPC and HIPP). I have been involved in the development of new diagnostic technologies for cancer mainly through glycoproteome analysis and proteome analysis of extracellular vesicles. Over the past decade, I feel that proteome analysis technologies have evolved so rapidly and is maturing.

At the same time, as is the case with the two initiatives in which I am currently participating, there is an accelerating trend toward the creation of new biology and clinical researches from large-scale integrated omics analyses such as proteogenomics. Such high-dimensional development requires further interdisciplinary fusion of not only proteomics researchers but also other omics researchers, statisticians, AI researchers, clinicians, and so on.

In fact, through my presentations at the HUPO World Congress, I have been able to initiate collaborative researches with basic biologists and companies around the world, which has greatly advanced my own clinical proteomics researches. Especially in 2013, when the HUPO World Congress was held in Japan, 1580 researchers from 42 countries participated, creating a very large number and a great deal of humanexchange in other fields.

I would like to make use of this experience and, if elected as a council member, I would like to work for the further development of HUPO in an interdisciplinary manner, including joint workshops with societies in other fields and the sharing of information on state-of-the-art technologies through SNS and other means. I also hope to discuss effective data sharing and data reuse methods related to the vast amount of data generated by the latest analytical instruments

Marc Wilkins

Deputy Dean (Research), Faculty of Science, and Professor of Systems Biology, University of New South Wales, Australia

Marc Wilkins developed the concept of the proteome and coined the term. He was the lead editor and co-author on the first book on proteomics (Proteome Research: new frontiers in functional genomics, 1997). He has been a researcher in the field of proteomics for 25+ years and has authored more than 270 publications. He served as a senior editor for PROTEOMICS over 10 years and, prior to that, as an editorial board member of ELECTROPHORESIS.

Marc has served HUPO over an extended period. He has been elected to and served on the Council of HUPO for five previous terms, contributing strongly in conference organisation. For HUPO 2010 in Sydney, Australia, he was co-convenor and program chair. He served on the international program committees of HUPO 2013 (Yokohama) and HUPO 2017 (Dublin). For HUPO 2019 in Adelaide, Australia, he was one of the 8-person organising committee. He was a moderator of the Proteomics 101 training program in HUPO 2021 ReConnect.

In Australia, since 2015, Marc has served on the Management Committee of the Australasian Proteomics Society. Since 2015 he has also served on the organising committee of the society's annual conference - the Lorne Proteomics Congress.

Marc is currently Professor and Deputy Dean (Research) at the University of New South Wales, in Sydney, Australia. His research interests are in protein methylation in the proteome, with a focus on its regulatory role in histones and the ribosome. He has been primary supervisor to completion of 16 PhD and 3 Masters research students, and primary supervisor of 38 undergraduate Honours students in their 1-year research program. All students undertook proteomics research.

Wei Wu

Principal Investigator/Associate Professor, A*STAR Singapore Immunology Network/National University of Singapore, Singapore

I first became a member of the HUPO council in 2022, as a diversity candidate from Central (Europe/Africa) region, when my laboratory was based in the Netherlands. It has been a wonderful experience working with other council members, in various HUPO initiatives and B/D-HPP communities, and very fulfilling to find diverse ways of contributing to this exciting proteomics community. In this period of service, I contributed to HUPO education days, chaired HUPO sessions, was the scientific chair of AOHUPO 2023, HUPO ECR manuscript judge, and even contributed to drafting a humanitarian statement for HUPO in the ongoing context of war.

My motivation to serve stems from the desire to give back what HUPO has taught me and provided for me during my own career and training. I understand that I had benefitted tremendously from learning and networking through HUPO events and training programmes, that I must serve in return to grow the HUPO community and provide the same opportunities for the next generation, and I must step up as an Asian female voice to speak for, and inspire, women in science in my continent. Hence I now seek re-election into the HUPO council as a representative of the Eastern (Asia/Oceania) region, from Singapore, where my lab is currently based. I will leverage my close connection to AOHUPO, and my local position as President of the Singapore Society of Mass Spectrometry (SSMS) to deepen the reach of HUPO into Asia.